Citation 7796

SHIRATAKI,Y: MOTOHASHI,N: TANI,S: SAKAGAMI,H: SATOH,K: NAKASHIMA,H: MAHAPATRA,SK: GANGULY,K: DASTIDAR,SG: CHAKRABARTY,AN:. (2001). IN VITRO BIOLOGICAL ACTIVITY OF PRENYLFLAVANONES.. 21(1A)

Citation Details

Title	IN VITRO BIOLOGICAL ACTIVITY OF PRENYLFLAVANONES.
Authors	SHIRATAKI,Y: MOTOHASHI,N: TANI,S: SAKAGAMI,H: SATOH,K: NAKASHIMA,H: MAHAPATRA,SK: GANGULY,K: DASTIDAR,SG: CHAKRABARTY,AN:
Year	2001
Volume	21
Issue	1A

Summary

Year: 2001

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
4	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
5	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
6	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
7	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
8	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
9	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
10	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
11	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
12	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
13	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
14	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
15	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	INACTIVE
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	INACTIVE
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	INACTIVE
19	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	INACTIVE
20	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	INACTIVE
21	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	WEAK ACTIVITY
22	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	EQUIVOCAL
23	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	INACTIVE
24	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	INACTIVE
25	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	INACTIVE
26	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	EQUIVOCAL
27	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	INACTIVE
28	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	EQUIVOCAL
29	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	EQUIVOCAL
30	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	INACTIVE
31	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-PRENYL:	WEAK ACTIVITY
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-PRENYL:	EQUIVOCAL
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-PRENYL:	EQUIVOCAL
34	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-PRENYL:	INACTIVE
35	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-PRENYL:	ACTIVE
36	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-PRENYL:	WEAK ACTIVITY
37	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-PRENYL:	INACTIVE
38	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-PRENYL:	INACTIVE
39	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-PRENYL:	WEAK ACTIVITY
40	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-PRENYL:	INACTIVE
41	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-PRENYL:	WEAK ACTIVITY
42	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-PRENYL:	INACTIVE
43	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-PRENYL:	INACTIVE
44	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-PRENYL:	WEAK ACTIVITY
45	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-PRENYL:	INACTIVE
46	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE B	WEAK ACTIVITY
47	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE B	WEAK ACTIVITY
48	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE B	WEAK ACTIVITY
49	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE B	INACTIVE
50	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE B	WEAK ACTIVITY
51	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE B	WEAK ACTIVITY
52	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE B	INACTIVE
53	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE B	INACTIVE
54	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE B	WEAK ACTIVITY
55	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE B	INACTIVE
56	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE B	WEAK ACTIVITY
57	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE B	INACTIVE
58	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE B	INACTIVE
59	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE B	WEAK ACTIVITY
60	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE B	INACTIVE
61	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	INACTIVE
62	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	INACTIVE
63	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	INACTIVE
64	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	WEAK ACTIVITY
65	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	WEAK ACTIVITY
66	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	WEAK ACTIVITY
67	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	INACTIVE
68	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	INACTIVE
69	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	EQUIVOCAL
70	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	INACTIVE
71	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	WEAK ACTIVITY
72	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	INACTIVE
73	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	INACTIVE
74	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	WEAK ACTIVITY
75	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	ACTIVE
76	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE G	WEAK ACTIVITY
77	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE G	WEAK ACTIVITY
78	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE G	WEAK ACTIVITY
79	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE G	WEAK ACTIVITY
80	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE G	WEAK ACTIVITY
81	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE G	WEAK ACTIVITY
82	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE G	INACTIVE
83	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE G	INACTIVE
84	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE G	WEAK ACTIVITY
85	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE G	INACTIVE
86	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE G	WEAK ACTIVITY
87	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE G	INACTIVE
88	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE G	INACTIVE
89	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE G	WEAK ACTIVITY
90	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE G	ACTIVE
91	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE D	WEAK ACTIVITY
92	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE D	EQUIVOCAL
93	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE D	EQUIVOCAL
94	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE D	INACTIVE
95	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE D	ACTIVE
96	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE D	WEAK ACTIVITY
97	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE D	INACTIVE
98	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE D	INACTIVE
99	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE D	WEAK ACTIVITY
100	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE D	INACTIVE
101	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE D	INACTIVE
102	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE D	INACTIVE
103	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE D	INACTIVE
104	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE D	EQUIVOCAL
105	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE D	ACTIVE
106	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	WEAK ACTIVITY
107	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	EQUIVOCAL
108	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	EQUIVOCAL
109	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	INACTIVE
110	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	ACTIVE
111	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	WEAK ACTIVITY
112	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	INACTIVE
113	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	INACTIVE
114	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	WEAK ACTIVITY
115	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	INACTIVE
116	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	INACTIVE
117	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	INACTIVE
118	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	INACTIVE
119	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	INACTIVE
120	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE A	INACTIVE
121	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE H	EQUIVOCAL
122	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE H	INACTIVE
123	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE H	INACTIVE
124	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE H	INACTIVE
125	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE H	STRONG ACTIVITY
126	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE H	WEAK ACTIVITY
127	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE H	INACTIVE
128	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE H	INACTIVE
129	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE H	INACTIVE
130	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE H	INACTIVE
131	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE H	INACTIVE
132	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE H	INACTIVE
133	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE H	INACTIVE
134	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE H	INACTIVE
135	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE H	ACTIVE
136	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE I	WEAK ACTIVITY
137	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE I	EQUIVOCAL
138	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE I	EQUIVOCAL
139	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE I	INACTIVE
140	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE I	ACTIVE
141	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE I	WEAK ACTIVITY
142	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE I	INACTIVE
143	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE I	INACTIVE
144	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE I	WEAK ACTIVITY
145	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE I	INACTIVE
146	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE I	INACTIVE
147	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE I	INACTIVE
148	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE I	INACTIVE
149	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE I	INACTIVE
150	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOPHORAFLAVANONE I	ACTIVE

Citation 7796

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1